HEADER CYTOKINE 01-MAY-92 1BCN TITLE THREE-DIMENSIONAL SOLUTION STRUCTURE OF HUMAN INTERLEUKIN-4 BY MULTI- TITLE 2 DIMENSIONAL HETERONUCLEAR MAGNETIC RESONANCE SPECTROSCOPY COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTERLEUKIN-4; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: POTENTIAL KEYWDS CYTOKINE EXPDTA SOLUTION NMR NUMMDL 22 AUTHOR G.M.CLORE,B.POWERS,D.S.GARRETT,A.M.GRONENBORN REVDAT 6 06-NOV-24 1BCN 1 REMARK REVDAT 5 05-JUN-24 1BCN 1 SEQADV REVDAT 4 24-FEB-09 1BCN 1 VERSN REVDAT 3 16-APR-99 1BCN 1 OBSLTE REVDAT 2 16-FEB-99 1BCN 1 OBSLTE REVDAT 1 31-OCT-93 1BCN 0 JRNL AUTH R.POWERS,D.S.GARRETT,C.J.MARCH,E.A.FRIEDEN,A.M.GRONENBORN, JRNL AUTH 2 G.M.CLORE JRNL TITL THREE-DIMENSIONAL SOLUTION STRUCTURE OF HUMAN INTERLEUKIN-4 JRNL TITL 2 BY MULTIDIMENSIONAL HETERONUCLEAR MAGNETIC RESONANCE JRNL TITL 3 SPECTROSCOPY. JRNL REF SCIENCE V. 256 1673 1992 JRNL REFN ISSN 0036-8075 JRNL PMID 1609277 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH R.POWERS,D.S.GARRETT,C.J.MARCH,E.A.FRIEDEN,A.M.GRONENBORN, REMARK 1 AUTH 2 G.M.CLORE REMARK 1 TITL THREE-DIMENSIONAL SOLUTION STRUCTURE OF HUMAN INTERLEUKIN-4 REMARK 1 TITL 2 BY MULTIDIMENSIONAL HETERONUCLEAR MAGNETIC RESONANCE REMARK 1 TITL 3 SPECTROSCOPY REMARK 1 REF SCIENCE V. 256 1673 1992 REMARK 1 REFN ISSN 0036-8075 REMARK 1 REFERENCE 2 REMARK 1 AUTH R.POWERS,D.S.GARRETT,C.J.MARCH,E.A.FRIEDEN,A.M.GRONENBORN, REMARK 1 AUTH 2 G.M.CLORE REMARK 1 TITL 1H, 15N, 13C AND 13CO ASSIGNMENTS OF HUMAN INTERLEUKIN-4 REMARK 1 TITL 2 USING THREE-DIMENSIONAL DOUBLE-AND TRIPLE-RESONANCE REMARK 1 TITL 3 HETERONUCLEAR MAGNETIC RESONANCE SPECTROSCOPY REMARK 1 REF BIOCHEMISTRY V. 31 4334 1992 REMARK 1 REFN ISSN 0006-2960 REMARK 1 REFERENCE 3 REMARK 1 AUTH D.S.GARRETT,R.POWERS,C.J.MARCH,E.A.FRIEDEN,G.M.CLORE, REMARK 1 AUTH 2 A.M.GRONENBORN REMARK 1 TITL DETERMINATION OF THE SECONDARY STRUCTURE AND FOLDING REMARK 1 TITL 2 TOPOLOGY OF HUMAN INTERLEUKIN-4 USING THREE-DIMENSIONAL REMARK 1 TITL 3 HETERONUCLEAR MAGNETIC RESONANCE SPECTROSCOPY REMARK 1 REF BIOCHEMISTRY V. 31 4347 1992 REMARK 1 REFN ISSN 0006-2960 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : NULL REMARK 3 AUTHORS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 DETAILS OF THE STRUCTURE DETERMINATION AND ALL STRUCTURAL REMARK 3 STATISTICS ARE GIVEN IN REFERENCE 1 (I.E. AGREEMENT WITH REMARK 3 EXPERIMENTAL RESTRAINTS, DEVIATIONS FROM IDEALITY FOR BOND REMARK 3 LENGTHS, ANGLES, PLANES AND CHIRALITY, NON-BONDED CONTACTS, REMARK 3 ATOMIC RMS DIFFERENCES BETWEEN THE CALCULATED STRUCTURES. REMARK 3 REMARK 3 THE STRUCTURES ARE BASED ON 823 INTERPROTON DISTANCE REMARK 3 RESTRAINTS FROM NOE MEASUREMENTS; 98 HYDROGEN-BONDING REMARK 3 DISTANCE RESTRAINTS FOR 49 HYDROGEN-BONDS IDENTIFIED ON REMARK 3 THE BASIS OF THE NOE AND AMIDE PROTON EXCHANGE DATA, AS REMARK 3 WELL AS THE INITIAL STRUCTURE CALCULATIONS; AND 101 PHI REMARK 3 AND 82 PSI BACKBONE TORSION ANGLE RESTRAINTS DERIVED FROM REMARK 3 COUPLING CONSTANTS, NOE DATA, AND 13C SECONDARY CHEMICAL REMARK 3 SHIFTS. REMARK 3 REMARK 3 THE METHOD USED TO DETERMINE THE STRUCTURES IS THE HYBRID REMARK 3 METRIC MATRIX DISTANCE GEOMETRY-DYNAMICAL SIMULATED REMARK 3 ANNEALING METHOD (M. NILGES, G. M. CLORE, AND A. M. REMARK 3 GRONENBORN FEBS LETT. 229, 317-324 (1988)). REMARK 3 REMARK 3 RESIDUES 1 - 6 AND 132 - 133 AT THE N- AND C-TERMINI ARE REMARK 3 DISORDERED. REMARK 3 REMARK 3 THE RESTRAINED MINIMIZED AVERAGE STRUCTURE IS PRESENTED IN REMARK 3 PROTEIN DATA BANK ENTRY 1BBN. THIS WAS OBTAINED BY REMARK 3 AVERAGING THE COORDINATES OF THE INDIVIDUAL STRUCTURES AND REMARK 3 SUBJECTING THE RESULTING COORDINATES TO RESTRAINED REMARK 3 MINIMIZATION. MODELS 1 - 22, PRESENTED IN THIS ENTRY, REMARK 3 REPRESENT THE INDIVIDUAL MODELS. REMARK 3 REMARK 3 THE (SA)R RESTRAINED MINIMIZED MEAN STRUCTURE WAS DERIVED REMARK 3 BY AVERAGING THE COORDINATES OF THE INDIVIDUAL SA REMARK 3 STRUCTURES (BEST FITTED TO RESIDUES 7 - 131), AND REMARK 3 SUBJECTING THE RESULTING COORDINATES TO RESTRAINED REMARK 3 MINIMIZATION. THE QUANTITY PRESENTED IN COLUMNS 61 - 66 IN REMARK 3 ENTRY 1BBN REPRESENTS THE ATOMIC RMS DEVIATIONS OF THE 22 REMARK 3 INDIVIDUAL SA STRUCTURES ABOUT THE MEAN STRUCTURE. REMARK 4 REMARK 4 1BCN COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000171595. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : NULL REMARK 210 PH : NULL REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NULL REMARK 210 SPECTROMETER FIELD STRENGTH : NULL REMARK 210 SPECTROMETER MODEL : NULL REMARK 210 SPECTROMETER MANUFACTURER : NULL REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : NULL REMARK 210 METHOD USED : NULL REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : NULL REMARK 210 CONFORMERS, NUMBER SUBMITTED : 22 REMARK 210 CONFORMERS, SELECTION CRITERIA : NULL REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 GLU A 3 -69.43 -124.01 REMARK 500 1 GLN A 24 59.98 -92.62 REMARK 500 1 THR A 26 -61.02 -162.08 REMARK 500 1 LEU A 31 -111.12 -75.15 REMARK 500 1 THR A 32 -173.04 -172.06 REMARK 500 1 VAL A 33 147.55 -175.59 REMARK 500 1 PHE A 37 30.78 -99.35 REMARK 500 1 ASP A 42 66.37 -161.69 REMARK 500 1 LEU A 70 -75.63 -54.24 REMARK 500 1 ALA A 72 63.38 -166.48 REMARK 500 1 CYS A 103 72.79 -153.14 REMARK 500 1 PRO A 104 88.17 -58.55 REMARK 500 1 VAL A 105 52.56 -99.08 REMARK 500 1 ASP A 109 -168.68 -69.17 REMARK 500 1 SER A 111 -168.71 -72.62 REMARK 500 1 SER A 129 41.70 -91.08 REMARK 500 1 LYS A 130 26.64 -159.47 REMARK 500 2 ALA A 2 32.90 -153.54 REMARK 500 2 HIS A 5 -79.01 -94.75 REMARK 500 2 LYS A 6 93.62 -177.41 REMARK 500 2 CYS A 7 -70.96 -152.95 REMARK 500 2 ILE A 9 -82.76 -70.75 REMARK 500 2 GLN A 24 77.42 -119.62 REMARK 500 2 LYS A 25 61.93 -119.39 REMARK 500 2 THR A 26 -52.97 -161.55 REMARK 500 2 LEU A 31 -122.90 -86.33 REMARK 500 2 LYS A 41 -46.38 -164.31 REMARK 500 2 ASP A 42 34.50 -154.27 REMARK 500 2 ALA A 72 50.10 -157.34 REMARK 500 2 ASN A 101 -70.17 -106.11 REMARK 500 2 CYS A 103 78.69 -165.45 REMARK 500 2 PRO A 104 89.98 -57.86 REMARK 500 2 LYS A 106 -67.54 -165.96 REMARK 500 2 GLU A 107 100.52 -52.89 REMARK 500 2 ALA A 108 133.36 -174.49 REMARK 500 2 GLN A 110 90.63 -68.89 REMARK 500 2 MET A 124 -74.39 -69.05 REMARK 500 3 ALA A 2 56.78 -96.25 REMARK 500 3 CYS A 7 73.10 0.15 REMARK 500 3 ASP A 8 -82.07 -89.55 REMARK 500 3 GLN A 24 65.47 -109.27 REMARK 500 3 LYS A 25 53.86 -99.31 REMARK 500 3 THR A 26 -66.17 -150.35 REMARK 500 3 GLU A 30 38.06 -89.81 REMARK 500 3 VAL A 33 -141.84 -139.98 REMARK 500 3 HIS A 63 33.41 -91.00 REMARK 500 3 CYS A 103 74.58 -150.45 REMARK 500 3 PRO A 104 88.29 -58.45 REMARK 500 3 GLU A 107 54.75 -169.23 REMARK 500 3 ALA A 108 139.31 -173.81 REMARK 500 REMARK 500 THIS ENTRY HAS 396 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1BBN RELATED DB: PDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE NUMBERING SCHEME IN THIS STRUCTURE INCLUDES THE REMARK 999 FOUR-RESIDUE SEQUENCE GLU-ALA-GLU-ALA AT THE N-TERMINUS OF REMARK 999 THE RECOMBINANT PROTEIN WHICH IS NOT PART OF THE NATURAL REMARK 999 HUMAN IL-4; THE NATURAL IL-4 SEQUENCE THEREFORE STARTS AT REMARK 999 RESIDUE 5. IN ADDITION, THE TWO POTENTIAL N-LINKED REMARK 999 GLYCOSYLATION SITES AT ASN 42 AND ASN 109 HAVE BEEN REMARK 999 CHANGED TO ASP BY SITE DIRECTED MUTAGENESIS TO PREVENT REMARK 999 HYPERGLYCOSYLATION IN THE YEAST HOST. DBREF 1BCN A 5 133 UNP P05112 IL4_HUMAN 25 153 SEQADV 1BCN ASP A 42 UNP P05112 ASN 62 CONFLICT SEQADV 1BCN ASP A 109 UNP P05112 ASN 129 CONFLICT SEQRES 1 A 133 GLU ALA GLU ALA HIS LYS CYS ASP ILE THR LEU GLN GLU SEQRES 2 A 133 ILE ILE LYS THR LEU ASN SER LEU THR GLU GLN LYS THR SEQRES 3 A 133 LEU CYS THR GLU LEU THR VAL THR ASP ILE PHE ALA ALA SEQRES 4 A 133 SER LYS ASP THR THR GLU LYS GLU THR PHE CYS ARG ALA SEQRES 5 A 133 ALA THR VAL LEU ARG GLN PHE TYR SER HIS HIS GLU LYS SEQRES 6 A 133 ASP THR ARG CYS LEU GLY ALA THR ALA GLN GLN PHE HIS SEQRES 7 A 133 ARG HIS LYS GLN LEU ILE ARG PHE LEU LYS ARG LEU ASP SEQRES 8 A 133 ARG ASN LEU TRP GLY LEU ALA GLY LEU ASN SER CYS PRO SEQRES 9 A 133 VAL LYS GLU ALA ASP GLN SER THR LEU GLU ASN PHE LEU SEQRES 10 A 133 GLU ARG LEU LYS THR ILE MET ARG GLU LYS TYR SER LYS SEQRES 11 A 133 CYS SER SER HELIX 1 1 ILE A 9 LEU A 21 1 13 HELIX 2 2 THR A 44 HIS A 62 1 19 HELIX 3 3 ASP A 66 GLY A 71 1 6 HELIX 4 4 THR A 73 GLY A 99 1 27 HELIX 5 5 THR A 112 TYR A 128 1 17 HELIX 6 6 SER A 129 CYS A 131 5 3 SHEET 1 A 2 VAL A 33 THR A 34 0 SHEET 2 A 2 GLN A 110 SER A 111 -1 O SER A 111 N VAL A 33 SSBOND 1 CYS A 7 CYS A 131 1555 1555 2.02 SSBOND 2 CYS A 28 CYS A 69 1555 1555 2.02 SSBOND 3 CYS A 50 CYS A 103 1555 1555 2.02 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1